# A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone

> **NCT00522431** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 149 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testosterone

## Key facts

- **NCT ID:** NCT00522431
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00522431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00522431, "A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00522431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*